Literature DB >> 34505223

Effects of SNVs in ABCA1, ABCG1, ABCG5, ABCG8, and SCARB1 Genes on Plasma Lipids, Lipoproteins, and Adiposity Markers in a Brazilian Population.

Vanessa Helena Souza Zago1, Daniel Zanetti Scherrer1, Eliane Soler Parra2, Isabela Calanca Vieira1, Fernando Augusto Lima Marson3,4,5, Eliana Cotta de Faria6.   

Abstract

Several proteins are involved in cholesterol homeostasis, as scavenger receptor class B type I and ATP-binding cassette (ABC) transporters including ABCA1, ABCG1, ABCG5, and ABCG8. This study aimed to determine the effects of single nucleotide variants (SNVs) rs2275543 (ABCA1), rs1893590 (ABCG1), rs6720173 (ABCG5), rs6544718 (ABCG8), and rs5888 (SCARB1) on plasma lipids, lipoproteins, and adiposity markers in an asymptomatic population and its sex-specific effects. Volunteers (n = 590) were selected and plasma lipids, lipoproteins, and adiposity markers (waist-to-hip and waist-to-height ratios, lipid accumulation product and body adiposity index) were measured. Genomic DNA was isolated from peripheral blood cells according to the method adapted from Gross-Bellard. SNVs were detected in the TaqMan® OpenArray® Real-Time polymerase chain reaction platform and data analyses were performed using the TaqMan® Genotyper Software. The rs2275543*C point to an increase of high-density lipoprotein size in females while in males very-low-density lipoprotein, cholesterol, and triglycerides were statistically lower (P value < 0.05). The rs1893590*C was statistically associated with lower apolipoprotein A-I levels and higher activities of paraoxonase-1 and cholesteryl ester transfer protein (P value < 0.05). The rs6720173 was statistically associated with an increase in cholesterol and low-density lipoprotein cholesterol in males; moreover, rs6544718*T reduced adiposity markers in females (P value < 0.05). Regarding the rs5888, a decreased adiposity marker in the total population and in females occurred (P value < 0.05). Multivariate analysis of variance showed that SNVs could influence components of high-density lipoprotein metabolism, mainly through ABCG1 (P value < 0.05). The ABCA1 and ABCG5 variants showed sex-specific effects on lipids and lipoproteins, while SCARB1 and ABCG8 variants might influence adiposity markers in females. Our data indicate a possible role of ABCG1 on HDL metabolism.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  ABCA1; ABCG1; ABCG5; ABCG8; SCARB1; Single nucleotide variant

Mesh:

Substances:

Year:  2021        PMID: 34505223     DOI: 10.1007/s10528-021-10131-1

Source DB:  PubMed          Journal:  Biochem Genet        ISSN: 0006-2928            Impact factor:   1.890


  62 in total

1.  Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency.

Authors:  A Brooks-Wilson; M Marcil; S M Clee; L H Zhang; K Roomp; M van Dam; L Yu; C Brewer; J A Collins; H O Molhuizen; O Loubser; B F Ouelette; K Fichter; K J Ashbourne-Excoffon; C W Sensen; S Scherer; S Mott; M Denis; D Martindale; J Frohlich; K Morgan; B Koop; S Pimstone; J J Kastelein; J Genest; M R Hayden
Journal:  Nat Genet       Date:  1999-08       Impact factor: 38.330

2.  Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters.

Authors:  K E Berge; H Tian; G A Graf; L Yu; N V Grishin; J Schultz; P Kwiterovich; B Shan; R Barnes; H H Hobbs
Journal:  Science       Date:  2000-12-01       Impact factor: 47.728

3.  Association of selected ABC gene family single nucleotide polymorphisms with postprandial lipoproteins: results from the population-based Hortega study.

Authors:  Rosario Abellán; María Luisa Mansego; Sergio Martínez-Hervás; Juan Carlos Martín-Escudero; Rafael Carmena; José Tomás Real; Josep Redon; José Javier Castrodeza-Sanz; Felipe Javier Chaves
Journal:  Atherosclerosis       Date:  2010-01-29       Impact factor: 5.162

4.  Common Variants in Cholesterol Synthesis- and Transport-Related Genes Associate with Circulating Cholesterol Responses to Intakes of Conventional Dairy Products in Healthy Individuals.

Authors:  Mohammad Mh Abdullah; Audrey Cyr; Marie-Claude Lépine; Peter K Eck; Patrick Couture; Benoît Lamarche; Peter Jh Jones
Journal:  J Nutr       Date:  2016-04-06       Impact factor: 4.798

5.  Reference values for high-density lipoprotein particle size and volume by dynamic light scattering in a Brazilian population sample and their relationships with metabolic parameters.

Authors:  F Alexandre; V H S Zago; N B Panzoldo; E S Parra; D Z Scherrer; F Vendrame; V S Nunes; E I L Gomes; P D Marcato; E R Nakandakare; E C R Quintão; E C de Faria
Journal:  Clin Chim Acta       Date:  2015-01-14       Impact factor: 3.786

6.  The combination of single nucleotide polymorphisms rs6720173 (ABCG5), rs3808607 (CYP7A1), and rs760241 (DHCR7) is associated with differing serum cholesterol responses to dairy consumption.

Authors:  Mohammad M H Abdullah; Peter K Eck; Patrick Couture; Benoît Lamarche; Peter J H Jones
Journal:  Appl Physiol Nutr Metab       Date:  2018-06-19       Impact factor: 2.665

7.  Association of polymorphisms at the SR-BI gene locus with plasma lipid levels and body mass index in a white population.

Authors:  S Acton; D Osgood; M Donoghue; D Corella; M Pocovi; A Cenarro; P Mozas; J Keilty; S Squazzo; E A Woolf; J M Ordovas
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-07       Impact factor: 8.311

8.  Identification of scavenger receptor SR-BI as a high density lipoprotein receptor.

Authors:  S Acton; A Rigotti; K T Landschulz; S Xu; H H Hobbs; M Krieger
Journal:  Science       Date:  1996-01-26       Impact factor: 47.728

Review 9.  The impact of APOA5, APOB, APOC3 and ABCA1 gene polymorphisms on ischemic stroke: Evidence from a meta-analysis.

Authors:  Anthony Au; Lyn R Griffiths; Looi Irene; Cheah Wee Kooi; Loo Keat Wei
Journal:  Atherosclerosis       Date:  2017-08-19       Impact factor: 5.162

Review 10.  Obesity paradox in cardiovascular disease: where do we stand?

Authors:  Salvatore Carbone; Justin M Canada; Hayley E Billingsley; Mohammad S Siddiqui; Andrew Elagizi; Carl J Lavie
Journal:  Vasc Health Risk Manag       Date:  2019-05-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.